European Association for the Study of Diabetes 2019 Conference: Podcast Overview of the Conference Uazman AlamShazli Azmi Editorial Open access 31 October 2019 Pages: 1 - 6
Sodium-Glucose Co-Transporter 2 Inhibitors and Fracture Risk Anastasia Erythropoulou-KaltsidouGeorgios PolychronopoulosKonstantinos Tziomalos Review Open access 16 November 2019 Pages: 7 - 14
Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment Viswanathan MohanKamlesh KhuntiJean C. Mbanya Review Open access 26 November 2019 Pages: 15 - 35
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes Marc EvansDebbie HicksUmesh Dashora Review Open access 07 December 2019 Pages: 37 - 52
Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11) Aslam AmodJohn B. Busethe DEVOTE Study Group Original Research Open access 30 October 2019 Pages: 53 - 70
The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance Yu-peng LiZhong-qing YanYun Xie Original Research Open access 30 October 2019 Pages: 71 - 81
The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies Mark EvansZoë WelshAlexander Seibold Original Research Open access 31 October 2019 Pages: 83 - 95
Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety Paola PonzaniCesare BerraMaria Chiara Rossi Original Research Open access 09 November 2019 Pages: 97 - 105
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study Fumiko YamamotoYuriko UnnoNaoyuki Hayashi Original Research Open access 11 November 2019 Pages: 107 - 117
Experiences of Attending Group Education to Support Insulin Initiation in Type 2 Diabetes: A Qualitative Study Rebecca UpsherMaya Allen-TaylorKirsty Winkley Original Research Open access 15 November 2019 Pages: 119 - 132
Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study Hitoshi IshiiYukiko OnishiMasakazu Takeuchi Original Research Open access 22 November 2019 Pages: 133 - 145
Efficacy and Safety of Switching Patients Inadequately Controlled on Basal Insulin to Insulin Glargine 300 U/mL: The TRANSITION 2 Study Pierre GourdyAmar BahloulBruno Guerci Original Research Open access 28 November 2019 Pages: 147 - 159
Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient’s Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data Diana ŠimonienėAksana PlatūkieneDžilda Veličkiene Original Research Open access 02 December 2019 Pages: 161 - 174
Comparative Effects of Three Kinds of Bariatric Surgery: A Randomized Case–Control Study in Obese Patients Dan LuoQingling YangYanjun Liu Original Research Open access 03 December 2019 Pages: 175 - 183
Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting Cheli Melzer-CohenGabriel ChodickAvraham Karasik Original Research Open access 05 December 2019 Pages: 185 - 196
Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site Toshihiko AranishiYukiko NagaiRimei Nishimura Original Research Open access 04 November 2019 Pages: 197 - 211
Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study Tam Dang-TanPravin S. KambleLibby Horter Original Research Open access 09 December 2019 Pages: 213 - 228
Impact of a Formulation Containing Unusual Polyunsaturated Fatty Acids, Trace Elements, Polyphenols and Plant Sterols on Insulin Resistance and Associated Disturbances María J. Peláez-JaramilloNatalia Valencia-EncisoCarlos O. Mendivil Original Research Open access 05 November 2019 Pages: 229 - 245
Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study Yulong ChenQuanmin LiYiming Mu Original Research Open access 10 December 2019 Pages: 247 - 257
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme Stephen C. BainBrian B. HansenMatthew Capehorn Original Research Open access 12 December 2019 Pages: 259 - 277
Three European Retrospective Real-World Chart Review Studies to Determine the Effectiveness of Flash Glucose Monitoring on HbA1c in Adults with Type 2 Diabetes Jens KrögerPeter FaschingHélène Hanaire Original Research Open access 12 December 2019 Pages: 279 - 291
Measurement Uncertainty Impacts Diagnosis of Diabetes Mellitus: Reliable Minimal Difference of Plasma Glucose Results Sandra KeutmannStephanie ZyllaAstrid Petersmann Original Research Open access 16 December 2019 Pages: 293 - 303
Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis Ádám G. TabákJohn AndersonJuris J. Meier Original Research Open access 17 December 2019 Pages: 305 - 318
Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy Louis S. MatzaBeatrice OsumiliKristina S. Boye Brief Report Open access 23 November 2019 Pages: 319 - 330
IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy Hirotaka WatadaBue F. Ross AgnerLiana K. Billings Brief Report Open access 23 November 2019 Pages: 331 - 339
The Diagnostic Utility of VibraTip for Distal Symmetrical Polyneuropathy in Type 2 Diabetes Mellitus Nikolaos PapanasKalliopi PafiliEfstratios Maltezos Brief Report Open access 28 November 2019 Pages: 341 - 346
Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial Cheol SonMasato KasaharaKiminori Hosoda Study Protocol Open access 01 November 2019 Pages: 347 - 358
INtegration of care for reaching targetS In Diabetic patiEnts: Design of the INSIDE Study Marco ComaschiAndrea Di LenardaAldo Pietro Maggioni Study Protocol Open access 22 November 2019 Pages: 359 - 367